跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BISACODYL 5 MG - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
BISACODYL 5 MG
Authorized
STANDARD
BISACODYL 5 MG
cellchem pharmaceuticals inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
c6f590ef74164b48
Company
cellchem pharmaceuticals inc.
Type
Standard
Approval Details
Approval Id
c6f590ef74164b48
Drug Approval Canada Name
BISACODYL 5 MG
Product Name
BISACODYL 5 MG
Status
Dormant
Status Date
2021-07-14
Original Market Date
2018-01-17
Din
02458845
Drug Class
Human
Dosage Form
Suppository
Route Of Administration
Rectal
Schedule
OTC
Ahfs
56:12.00
Atc Original
A06AB02 BISACODYL
Atc Name
a 06 ab 02
Aig Number
0101506001
Company Name
cellchem pharmaceuticals inc.
Company Address
UNIT 1, 30 Concourse Gate, Ottawa, Ontario, Canada, K2E 7V7
Active Ingredients
BISACODYL
5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
c6f590ef74164b48
Type
Standard
Back to Health Canada Approvals